Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 2,49€(+85,82%). Der Median liegt bei 2,49€(+85,82%).
Kaufen | 7 |
Halten | 1 |
Verkaufen | 0 |
Scoring-Modelle
Dividenden-Strategie | 0 / 15 |
HGI-Strategie | 6 / 18 |
Levermann-Strategie | -7 / 13 |
News
DocGo Announces Upcoming Participation at the Goldman Sachs 46th Annual Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that Lee Bienstock, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9th from 4:00 – 4:35 PM Eastern Time, and hold 1x1 meetings as well. A webcast of the event will be available on the investor relations section of DocGo's website at ht.» Mehr auf businesswire.com
Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders.» Mehr auf globenewswire.com
Kuehn Law Encourages Investors of DocGo, Inc. to Contact Law Firm
NEW YORK , May 29, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DocGo, Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, DocGo insiders caused the company to misrepresent or fail to disclose that (i) the processes DocGo used to hire executives were insufficient for thoroughly examining and verifying the professional and educational backgrounds of applicants; (ii) this inadequacy heightened the risk of disruptive changes in executive leadership; (iii) contrary to what it had communicated to investors, DocGo had overestimated the effectiveness of its mobile health and medical transportation services, which were key components of the Relocation Contract; (iv) all these issues, once disclosed, were likely to expose DocGo to considerable reputational and/or regulatory examination, adversely affecting the company's financial health and future outlook; and (v) consequently, the company's public declarations were inaccurate and misleading throughout the times in question.» Mehr auf prnewswire.com
Unternehmenszahlen
(EUR) | März 2025 | |
---|---|---|
Umsatz | 88,77 Mio | 50,13% |
Bruttoeinkommen | 28,51 Mio | 51,23% |
Nettoeinkommen | −8,69 Mio | 183,57% |
EBITDA | −9,81 Mio | 152,80% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 132,70 Mio€ |
Anzahl Aktien | 99,10 Mio |
52 Wochen-Hoch/Tief | 4,97€ - 1,08€ |
Dividenden | Nein |
Beta | 0,94 |
KGV (PE Ratio) | −242,64 |
KGWV (PEG Ratio) | 2,38 |
KBV (PB Ratio) | 0,50 |
KUV (PS Ratio) | 0,29 |
Unternehmensprofil
DocGo, Inc. bietet mobile Gesundheits- und medizinische Transportdienste für verschiedene Gesundheitsdienstleister in den Vereinigten Staaten und im Vereinigten Königreich an. Die Transportdienste des Unternehmens umfassen Notfalldienste und Nicht-Notfall-Transportdienste wie Krankenwagen- und Rollstuhltransportdienste. Außerdem bietet es über seine Plattform mobile Gesundheitsdienste, die zu Hause und im Büro durchgeführt werden, COVID-19-Tests und Veranstaltungsdienste, die eine medizinische Betreuung vor Ort bei Sportveranstaltungen und Konzerten umfassen. DocGo, Inc. wurde im Jahr 2015 gegründet und hat seinen Hauptsitz in New York, New York.
Name | DocGo A Aktie |
CEO | Lee Bienstock |
Sitz | New York City, ny USA |
Website | |
Industrie | Gesundheitswesen: Anbieter und Dienstleister |
Börsengang | |
Mitarbeiter | 3.404 |
Ticker Symbole
Börse | Symbol |
---|---|
NASDAQ | DCGO |
Assets entdecken
Shareholder von DocGo A Aktie investieren auch in folgende Assets